Financial results - KRILUM PARAFARMACEUTICS SRL

Financial Summary - Krilum Parafarmaceutics Srl
Unique identification code: 18448644
Registration number: J15/214/2006
Nace: 4619
Sales - Ron
-
Net Profit - Ron
-386
Employees
Open Account
Company Krilum Parafarmaceutics Srl with Fiscal Code 18448644 recorded a turnover of 2024 of - , with a net profit of -386 and having an average number of employees of - . The company operates in the field of Intermedieri în comerţul cu produse diverse having the NACE code 4619.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Krilum Parafarmaceutics Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 88.197 126.565 152.726 151.959 137.629 0 0 0 0 0
Total Income - EUR 93.081 136.616 170.002 153.753 146.296 0 0 0 0 0
Total Expenses - EUR 91.211 131.644 158.700 141.856 153.282 6.166 5.843 5.897 715 386
Gross Profit/Loss - EUR 1.870 4.971 11.302 11.897 -6.986 -6.166 -5.843 -5.897 -715 -386
Net Profit/Loss - EUR 1.571 4.190 9.494 10.360 -6.986 -6.166 -5.843 -5.897 -715 -386
Employees 0 0 1 1 1 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Krilum Parafarmaceutics Srl

Rating financiar

Financial Rating -
KRILUM PARAFARMACEUTICS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Krilum Parafarmaceutics Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Krilum Parafarmaceutics Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Krilum Parafarmaceutics Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Krilum Parafarmaceutics Srl - CUI 18448644

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 0 10.902 35.206 28.517 22.083 15.830 0 0 0
Current Assets 9.728 18.439 14.615 14.171 5.840 3.447 3.291 3.185 2.460 2.061
Inventories 0 0 52 0 1.217 0 0 0 0 0
Receivables 4.236 4.502 1.418 10.456 4.609 536 540 564 698 767
Cash 5.491 13.937 13.145 3.715 14 2.911 2.751 2.622 1.762 1.294
Shareholders Funds 5.911 10.041 30.266 40.070 32.308 25.530 19.121 3.185 2.460 2.061
Social Capital 45 45 10.945 10.745 10.537 10.337 10.108 10.139 10.108 10.052
Debts 5.740 10.303 1.314 14.030 2.049 0 0 0 0 0
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4619 - 4619"
CAEN Financial Year 4619
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.061 euro in 2024 which includes Inventories of 0 euro, Receivables of 767 euro and cash availability of 1.294 euro.
The company's Equity was valued at 2.061 euro, while total Liabilities amounted to 0 euro. Equity decreased by -386 euro, from 2.460 euro in 2023, to 2.061 in 2024.

Risk Reports Prices

Reviews - Krilum Parafarmaceutics Srl

Comments - Krilum Parafarmaceutics Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.